FDA Warning Letter — Raphe Generics Corp
The FDA took a Warning Letter action against Raphe Generics Corp on Jan 29, 2025 (Garland, TX). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Raphe Generics Corp
- Date
- Jan 29, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Garland, TX (United States)